Discover How Helix is Changing the World of Healthcare
Resources Hub
Dr. James Lu, Helix, on making Genomics the Backbone of Preventive Healthcare
American College of Medical Genetics and Genomics 2025 Posters
Individuals with PMS2 pathogenic variants are at average risk of cancer before age 60
Scalable system-wide CYP2C19 pharmacogenomic testing reveals 38% excess incidence of adverse events in metabolizers receiving inappropriate prescriptions
Population genomic screening leads to improved lipid management in patients with familial hypercholesterolemia
Helix Launches 23,000-Patient Clinico-Genomic Cohort for Autoimmune Diseases to Advance Drug Discovery and Development
Helix Unveils Groundbreaking Real-World Insights at the ACMG Annual Clinical Genetics Meeting, Driving Clinical Care Forward
Metabolic risk factors and BMI-associated variants influencing weight loss with Semaglutide
The Latest Content From Helix
Recent Blog Posts
View All Blog Posts
Blog
Advancing Cancer Care: Helix's New DPYD Testing for Safer Chemotherapy
By MD, FACP, FACMG Cassie Hajek, Medical Director at Helix
Blog
Population Genomics: Personalizing Genetic Breast Cancer Screening
Blog
Unraveling the Power of Germline Clinico-Genomic Data: A Game Changer in Pharma's Drug Development Lifecycle
Blog
Preventable hospitalizations with increased oral SARS-CoV-2 antiviral treatment
Recent Press Releases
View All Press ReleasesPress Releases
Helix Launches 23,000-Patient Clinico-Genomic Cohort for Autoimmune Diseases to Advance Drug Discovery and Development
Press Releases
Helix Unveils Groundbreaking Real-World Insights at the ACMG Annual Clinical Genetics Meeting, Driving Clinical Care Forward
Press Releases
Helix Launches World's Largest Clinico-Genomic Cohort of GLP-1 Agonist Treated Patients
Recent Videos
View All Videos
Recent Published Research
View All Published Research1
Published Research
Individuals with PMS2 pathogenic variants are at average risk of cancer before age 60
2
Published Research
Scalable system-wide CYP2C19 pharmacogenomic testing reveals 38% excess incidence of adverse events in metabolizers receiving inappropriate prescriptions
3
Published Research
Population genomic screening leads to improved lipid management in patients with familial hypercholesterolemia
4
Published Research
Underestimated risk of secondary complications in pathogenic and glucose-elevating GCK variant carriers with type 2 diabetes
5
Published Research